Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha - Wikidata - wikimedia - TriplyDB

Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha

Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha

http://www.wikidata.org/entity/Q34009839

about

Dinosaurs and ancient civilizations: reflections on the treatment of cancer Polyunsaturated fatty acid metabolism in prostate cancer The Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory Diseases Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment Tyrosine phosphorylation in Toll-like receptor signaling Mucins and toll-like receptors: kith and kin in infection and cancer Suitability of endogenous reference genes for gene expression studies with human intraocular endothelial cells SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation.Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.The interconnectedness of cancer cell signaling.TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4 pathway.Toll-like receptors in prostate infection and cancer between bench and bedside Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors.Oxidative stress in angiogenesis and vascular disease Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.Toll-like receptors: new players in myocardial ischemia/reperfusion injury.Inflammation and oxidative stress in angiogenesis and vascular disease.Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema.Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Toll-like receptors and prostate cancer.Red blood cell, hemoglobin and heme in the progression of atherosclerosis Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.Double-stranded RNA induces chicken T-cell lymphoma apoptosis by TRIF and NF-κB Hypoxia and the hypoxia-regulated transcription factor HIF-1α suppress the host defence of airway epithelial cells.Toll-like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF.Biological and pathophysiological roles of end-products of DHA oxidation.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.Poly(I:C) treatment influences the expression of calreticulin and profilin-1 in a human HNSCC cell line: a proteomic study.Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA.The dual role of TLR3 in metastatic cell line.Exploiting poly(I:C) to induce cancer cell apoptosis.Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response.Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration Androgen depletion augments antibacterial prostate host defences in rats.Toll-like receptor 3 activation in retinal pigment epithelium cells - Mitogen-activated protein kinase pathways of cell death and vascular endothelial growth factor secretion.Toll-like receptor 3 regulates cord blood-derived endothelial cell function in vitro and in vivo.Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy.

P2860

Q24628746-CA645504-E72B-4739-A160-A40CFDA8DA73 Q24629893-AFB439D9-7D11-44D6-9572-B1969163D1B4 Q26749138-0068EB06-3969-49E3-B090-390EF7F3D486 Q26825259-0D07CDCA-5741-48FF-964F-42A4AF1F2FEE Q26828015-833D0E01-A79A-4617-A8DF-0FF3DB64BEE4 Q26830597-49CAAD7A-E790-4E6B-BFD8-68E993D0D106 Q34573908-76AD76B5-42A2-4FF2-8567-3AE87C06AED9 Q34662257-16165A6C-481F-46A9-A866-3834467874B3 Q35126624-0CE36A1A-E350-4E58-A36D-E5338911D978 Q35531400-3EF8794E-7C1C-41C6-A338-2E451CE9A9EB Q35669733-9BC3A7D2-F3E7-4C7F-9395-113DB5E4927C Q36976363-07D0ED3F-E0F7-4D0B-B644-B2FB1E13D653 Q37295411-F1413677-015C-4903-8302-8FB038F592FE Q37457484-6EB77E9A-40BD-4964-A830-6BEE00D79D7F Q37535220-70FFA0A1-ACD7-4B66-AF4D-AA6727675BCE Q37696181-B3B5F93B-1304-4F58-A7DD-27AD90A80916 Q37810952-52DA4DE3-BBE5-4B46-A6DE-D192380FBC0A Q38083584-1DF28F73-0848-42F0-9C13-92B77A09AA22 Q38104680-9AEDEC07-4857-4071-BC08-66F10A9E5AE7 Q38162098-22133B21-1781-48C6-BDDE-5B8CFAC7DDEC Q38237640-AE17C207-BA6A-471A-83B9-C3572DE8B3EB Q38261012-EA465E70-3AE8-46D2-A82C-600405888B36 Q38478654-8612186E-9391-42C0-83F8-E452C7E7811C Q38695407-8879F58B-AA0A-45C2-ADAA-5C678DD9F18C Q38707688-EB6B4888-2EC1-4384-B46A-FEC8A2DA306B Q38734150-717C3891-A9DC-40BB-A603-7B9F4B1D605C Q38974093-66B30B75-E961-4825-A5FE-FE0060835390 Q39377049-C0EDABA5-A502-4221-AF3D-F784CD353EB9 Q39380343-837E48C4-A3B6-4C4A-861C-9D615D40D18B Q39447134-F01A375E-403A-46FE-A6BE-4996D4AFDAAD Q39511419-F0A5C168-7435-46C9-95C0-20828475FEC0 Q40062585-087A74B6-7526-4972-ADEB-7752C8B38BFB Q40202451-C87D7275-F2EA-467D-AA6A-F29A14AA20DA Q40516283-142BF229-FE60-4E6A-8600-7957960FFC9E Q40893702-B1BF740B-46BE-4C56-808C-B6A4689B5E1A Q41879186-B983F823-9799-4B42-86AB-8231E2E4AEEB Q47603855-88DEC526-2161-4F30-8D3A-90BD7C613DD0 Q50237265-B5035C31-2BFD-4607-B7C5-EC0655A6C77B Q50924641-0E7A1079-27EB-4333-844E-236C35AD60AE Q54112790-2112542C-5724-48EF-99C2-81C33404286F

P2860

Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha

http://www.wikidata.org/entity/Q34009839

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@ast

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@en

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@nl

type

label

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@ast

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@en

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@nl

prefLabel

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@ast

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@en

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@nl

P1433

Q34009839-A6BDC539-4F88-4DF7-833F-8BA3AF2D8B1F

P1476

Q34009839-89E10FD2-D9DE-47A3-8311-79CD2DD3B866

P2093

Q34009839-3AF41FDB-F7FB-4CBB-8E44-43305CF7DCD5

Q34009839-6178E718-F88B-417A-9E56-4CF14B1E5175

Q34009839-6B12E53F-34B9-423E-9DD0-4B226334493B

Q34009839-C72ECEA1-EA81-4092-ACAE-7A53E1601144

Q34009839-CE8D9124-A1A9-47BE-897B-826D5E769FC1

Q34009839-E0596265-65D4-4E81-851D-E910DEBD2BBA

Q34009839-E4E1E186-88F7-413E-BC32-E72EB2E1F77B

P2860

Q34009839-06CC6E33-9B08-4CB2-B327-7F8948EF11F8

Q34009839-07AE4BCC-2F90-4AED-918E-97C7EA081388

Q34009839-08BA203C-D101-411D-A419-3A97EE3EC717

Q34009839-0B30B8D9-AEBA-4A8F-90C2-75FB4201EC2A

Q34009839-0D1649DF-C977-483D-B5A7-3ACFC9130E3C

Q34009839-107DB2DD-C83C-445D-A7A4-BA2AB9932388

Q34009839-15F0E936-3F27-42AE-9780-203E50E5AEE3

Q34009839-16DBE38D-D972-4148-BAE3-A994A7B889CF

Q34009839-1F6D7D72-9F92-40E2-A74E-35B0F57E0E0F

Q34009839-2642F4DA-DA5B-4405-874C-1B71DE61C2EC

P304

Q34009839-499BEE98-37FC-4881-B863-0F4CD9986C89

P31

Q34009839-E900A830-7E5F-476C-8BBE-7A4D63CD089D

P356

Q34009839-1ED9FEC1-6814-402D-AB3F-B43EAB0317F8

P433

Q34009839-514C8DE3-9537-402D-8352-A7DE05BCDF73

P478

Q34009839-BB63AA24-05F8-40C7-907A-35F5AF719562

P50

Q34009839-11D2398E-1A4B-4BB6-B040-E64F9AD04C10

Q34009839-36DE7344-A37C-4DF3-B570-7D93A7B12679

Q34009839-50EC66DE-DADF-4011-BEB0-6C3797FB33D2

Q34009839-8BA6887F-A250-4258-A799-6B4DD194C688

Q34009839-F12D2843-5837-4654-82F6-0D226F5CA3FE

P577

Q34009839-C1218C1F-0134-4994-922C-0C9C6AC7D63D

P5875

Q34009839-628CBEC5-F3CD-4418-9281-CCF0F09774E2

P698

Q34009839-1E3D3F93-9720-44F3-B003-E79AEBDA9E97

P921

Q34009839-2E0599FC-F062-473F-BAA6-E3991DA00D4A

Q34009839-A2CC54D7-D0A8-45A3-8639-020B02411E24

P932

Q34009839-D974614C-F5EE-431D-A405-47AC7C6D7582

P356

P1433

P1476

Toll-like receptor 3 regulates ...... poxia-inducible factor 1 alpha

@en

P2093

Agnes Gorlach

http://www.w3.org/2001/XMLSchema#string

Anna Riccioli

http://www.w3.org/2001/XMLSchema#string

Antonio Filippini

http://www.w3.org/2001/XMLSchema#string

Dmitriy Lukashev

http://www.w3.org/2001/XMLSchema#string

Donatella Starace

http://www.w3.org/2001/XMLSchema#string

Michail V Sitkovsky

http://www.w3.org/2001/XMLSchema#string

Roberta Galli

http://www.w3.org/2001/XMLSchema#string

P2860

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

Pathogen recognition and innate immunity

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation

Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site

Toll-like receptor control of the adaptive immune responses

High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.

Development of HIF-1 inhibitors for cancer therapy

VEGF and the quest for tumour angiogenesis factors.

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.

P304

539-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.92106

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Donatella Del Bufalo

Paola De Cesaris

Chiara Gabellini

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45282947

http://www.w3.org/2001/XMLSchema#string

P698

20651983

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2907580

http://www.w3.org/2001/XMLSchema#string